US 7,579,470 B2
	Fused heterocyclic compounds
Curt A. Dvorak, San Diego, Calif. (US); and Dale A. Rudolph, San Diego, Calif. (US)
Assigned to Janssen Pharmaceutica NV, Beerse (Belgium)
Filed on Oct. 25, 2007, as Appl. No. 11/924,277.
Application 11/924277 is a continuation of application No. 10/941664, filed on Sep. 15, 2004, granted, now 7,402,680.
Claims priority of provisional application 60/552673, filed on Mar. 11, 2004.
Claims priority of provisional application 60/504528, filed on Sep. 17, 2003.
Prior Publication US 2008/0103132 A1, May 01, 2008
Int. Cl. C07D 417/02 (2006.01); A01N 43/42 (2006.01)

U.S. Cl. 546—113  [546/119; 514/300; 514/303]

2 Claims

1. A compound which is any one of 3-(4-Fluoro-phenyl)-2-isopropyl-2,4,5,6,7,8-hexahydro-1,2,6-triaza-azulene and pharmaceutically acceptable salts thereof.